Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
4.960
+0.060 (1.22%)
Sep 28, 2026, 2:27 PM EDT - Market open
Champions Oncology Revenue
Champions Oncology had revenue of $15.23M in the quarter ending July 31, 2026, with 8.84% growth. This brings the company's revenue in the last twelve months to $60.66M, up 6.65% year-over-year. In the fiscal year ending April 30, 2026, Champions Oncology had annual revenue of $59.43M with 4.36% growth.
Revenue (ttm)
$60.66M
Revenue Growth
+6.65%
P/S Ratio
1.12
Revenue / Employee
$283,467
Employees
214
Market Cap
69.04M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2026 | 59.43M | 2.48M | 4.36% |
| Apr 30, 2025 | 56.94M | 6.79M | 13.54% |
| Apr 30, 2024 | 50.16M | -3.72M | -6.90% |
| Apr 30, 2023 | 53.87M | 4.76M | 9.69% |
| Apr 30, 2022 | 49.11M | 8.07M | 19.66% |
| Apr 30, 2021 | 41.04M | 8.92M | 27.76% |
| Apr 30, 2020 | 32.12M | 5.06M | 18.68% |
| Apr 30, 2019 | 27.07M | 6.83M | 33.72% |
| Apr 30, 2018 | 20.24M | 4.83M | 31.34% |
| Apr 30, 2017 | 15.41M | - | - |
| Apr 30, 2016 | - | - | - |
| Apr 30, 2015 | - | - | - |
| Apr 30, 2014 | - | - | - |
| Apr 30, 2013 | - | - | - |
| Apr 30, 2012 | - | - | - |
| Apr 30, 2011 | - | - | - |
| Apr 30, 2010 | - | - | - |
| Apr 30, 2009 | 3.71M | 2.31M | 165.00% |
| Apr 30, 2008 | 1.40M | - | - |
| Apr 30, 2007 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Gossamer Bio | 53.29M |
| Spero Therapeutics | 47.00M |
| MindWalk Holdings | 11.57M |
| Alps Group | 3.74M |
| Connect Biopharma Holdings | 2.95M |
| Alterity Therapeutics | 2.50M |
CSBR News
- 17 days ago - Champions Oncology Earnings Call Transcript: Q1 2027 - Transcripts
- 17 days ago - Champions Oncology Earnings release: Q1 2027 - Filings
- 17 days ago - Champions Oncology Quarterly report: Q1 2027 - Filings
- 17 days ago - Champions Oncology reports Q1 adjusted EPS 5c vs. 1c last year - TheFly
- 17 days ago - Champions Oncology Reports Revenue of $15.2 Million - Accesswire
- 24 days ago - Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026 - Accesswire
- 27 days ago - Champions Oncology expands integrated radiopharmaceutical development platform - TheFly
- 4 weeks ago - Champions Oncology Proxy statement: Proxy filing - Filings